Business
Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting
Medison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Votin...
About this update from Knight Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\nMedison Urges Fellow Shareholders to Bring Positive Change to Knight Therapeutics by Voting for All Six of Medison's Highly Qualified Nominees at Upcoming Annual Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nPETACH TIKVA, Israel, April 29, 2019\n\n\n\nFailures at Knight have been exposed by multiple, independent third parties Change can only be assured if all Medison nominees are elected Conflicts, related-party transactions and an on-going failure to create value for shareholders must come to an end Medison also calls on Knight shareholders to vote FOR Medison's proposed Enhanced Governance Bylaw to strengthen governance and eliminate current conflicts among Board and CEO PETACH TIKVA, Israel, April 29, 2019 /CNW/ - Medison Biotech (1995) Ltd. (\"Medison\"), which together with its affiliates owns more than 10.4 million shares or 7.3% of Knight Therapeutics, Inc. (TSX:GUD) (\"Knight\" or the \"Company\"), today publicly issued a letter to its fellow Knight shareholders, calling on them to vote FOR the entire Medison slate of highly qualified directors on the GOLD proxy card, before this Thursday's deadline for the 2019 annual and special meeting.  \nExplaining why electing anything but the full slate would be insufficient to effect meaningful change, Meir Jakobsohn, CEO of Medison, said, \"All shareholders must send a clear and unequivocal message that we want Knight to move forward with discipline and urgency – putting idle cash to work to create value for shareholders and adopting a proven business plan that will create a growing and profitable company.\" \nAdded Jakobsohn, \"This Board must change drastically if shareholders are to see meaningful change in the business or stock price.  We have nominated an exceptional, independent group of highly skilled candidates ready to move Knight forward immediately.  We ask all shareholders that have not yet voted to join us and the other shareholders that have committed to electing all of the Medison directors.  It can be a n...